BridgeBio Pharma (NASDAQ: BBIO) Stock Skyrockets on Positive Late-Stage Trial Results for Heart Drug
Shares of BridgeBio Pharma, (NASDAQ: BBIO) skyrocketed 48.84% in pre-market trading on Monday. This surge followed the positive outcomes exhibited […]
